Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting of post-introduction COVID-19 vaccine effectiveness evaluations.
Full bibliographic reference
Patel MK, Bergeri I, Bresee JS, Cowling BJ, Crowcroft NS, Fahmy K, Hirve S, Kang G, Katz MA, Lanata CF, L’Azou Jackson M, Joshi S, Lipsitch M, Mwenda JM, Nogareda F, Orenstein WA, Ortiz JR, Pebody R, Schrag SJ, Smith PG, Srikantiah P, Subissi L, Valenciano M, Vaughn DW, Verani JR, Wilder-Smith A, Feikin DR. Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization. Vaccine. 2021:S0264-410X(21)00707-6.
Language
English
PubMed ID
Relevant URLs (full-text if available)
The full-text of this guideline is freely available.
Table 4 presents an extension to the Strengthening the reporting of observational studies in epidemiology (STROBE) checklist with recommended additional elements for reporting COVID-19 vaccine effectiveness studies.
Study design
Observational studies
Clinical area
Infectious diseases, Public health
Applies to the whole report or to individual sections of the report?
Whole report
Other
Linkins LA, Iorio A, Little J, Lavis J. Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19. Vaccine. 2022:S0264-410X(22)00422-4. PMID: 35443916
Record last updated on
April 29, 2022
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.